IGC Pharma

Call Website Contact the business

Advancing Alzheimer's research through therapeutic innovation and AI.

Sharing research, education and resources for patients, caregivers and the Alzheimer’s community. About IGC Pharma (dba IGC):

IGC Pharma is an AI-powered, clinical-stage biotechnology company focused on developing innovative treatments for Alzheimer's disease and transforming patient care with fast-acting, safe, and effective solutions. Our portfolio includes the TGR family, including TGR-63, which targets amyloid plaques, a hallmark of Alzheimer's. The IGC-C and IGC-M platforms are advancing in preclinical studies, focusing on metabolic disorders, tau proteins, early plaque formation, and multiple disease hallmarks. Our lead therapeutic candidate, IGC-AD1, is a cannabinoid-based treatment currently in a Phase 2 trial for agitation in dementia associated with Alzheimer's (clinicaltrials.gov, NCT05543681). Clinical data for IGC-AD1 demonstrated that it has the potential to transform patient care by offering faster-acting and more effective relief compared to traditional medications. Additionally, our AI models are designed to predict potential biomarkers for the early detection of Alzheimer's, optimize clinical trials, and predict receptor affinity, among others. With 28 patent filings and a commitment to innovation, IGC Pharma is dedicated to advancing pharmaceutical treatments and improving the lives of those affected by Alzheimer's and related conditions.

10/20/2026

Alzheimer's research involves enormous amounts of information, from medical histories and cognitive assessments to brain imaging and genetic data.

AI is helping researchers explore this information in new ways, identifying patterns and relationships that may be difficult to detect through traditional methods.

Sources: Alzheimer's Association (2025); Nature Reviews Neurology (2024); npj Digital Medicine (2024)

10/18/2026

Not every memory lapse is a sign of Alzheimer's disease, but changes in memory or thinking shouldn't automatically be dismissed as part of aging.

Memory difficulties can have different causes, including some that are treatable. If you notice changes that concern you or someone close to you, speaking with a healthcare professional can help you better understand what's happening.

10/13/2026

PRISM is the latest step in IGC Pharma's Alzheimer's AI strategy.

Designed to bring the Company's patent-pending MINT-AD platform closer to real-world healthcare applications, PRISM is intended to move AI-generated Alzheimer's risk insights into action through structured workflows that may support individuals, clinicians, care teams, and commercial partners seeking earlier, more informed approaches to brain health.

Read the full press release: https://igcpharma.com/igc-pharma-unveils-prism-ai-platform-to-move-alzheimers-risk-prediction-to-brain-health-action-and-commercial-deployment/

09/29/2026

Sleep is more than a time to rest. It is an active biological process that plays an essential role in maintaining brain health.

Growing research suggests that sleep quality may influence long-term cognitive health, and scientists are studying sleep as a potential modifiable factor in Alzheimer's disease research.

Understanding this connection may help advance Alzheimer's research and contribute to new approaches to supporting lifelong brain health.

Read the full article: https://igcpharma.com/how-sleep-supports-brain-health/

Author: Juan David Caicedo-Narváez, MD, PhD(c), Medical Writer

09/28/2026

With target enrollment complete, IGC Pharma’s Phase 2 CALMA Alzheimer’s trial has officially transitioned from recruitment to the final stage ahead of topline results.

The Company’s focus is now on patient follow-up and database lock as it prepares the 168-patient dataset for rigorous scientific and regulatory evaluation and potential next-stage development.

Read the full press release: https://igcpharma.com/igc-pharma-completes-enrollment-in-phase-2-calma-alzheimers-trial-topline-results-expected-q4-2026/

09/27/2026

Brain health is influenced by many factors throughout life.

Traumatic brain injuries can have long-lasting effects on the brain. Researchers continue to study whether these changes contribute to a higher risk of cognitive decline and Alzheimer's disease later in life.

09/21/2026

Alzheimer's disease affects millions of people around the world, and every journey is unique.

This World Alzheimer's Day, we recognize the individuals living with Alzheimer's disease, the families and caregivers who support them, the healthcare professionals who provide care, and the researchers working every day to better understand this complex disease.

Together, research, education, and awareness help move us toward a better understanding of Alzheimer's and its impact on people's lives.

09/14/2026

As Alzheimer's disease progresses, communication can become more complex, for both the person living with the disease and those around them.

Understanding how these changes affect everyday interactions can help caregivers approach conversations with greater confidence.

09/08/2026

Changes in behavior during the late afternoon or evening can be challenging for both people living with Alzheimer's disease and their caregivers.

Researchers continue to study why these changes occur and the factors that may contribute to them. Recognizing these patterns may help caregivers better understand what their loved one is experiencing and support informed conversations with healthcare professionals.

09/06/2026

Connection doesn't always come through words.

It can be found in listening to a favorite song, sharing a walk, preparing a meal together, or simply spending time side by side. These everyday moments can bring comfort and strengthen the bond between caregivers and people living with Alzheimer's disease.

Looking for more practical caregiving guidance? Download Caring for a Loved One with Alzheimer's Disease: First-Hand Experiences, a free resource supported by IGC Pharma.

Download your copy:https://igcpharma.com/wp-content/uploads/2025/12/Alzheimers_Caregivers-English-_Version.pdf

Address

Potomac, MD

Telephone

+13019830998

Website

https://igcpharma.com/

Alerts

Be the first to know and let us send you an email when IGC Pharma posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to IGC Pharma:

Cosmetic Surgery, Laser Services, ,Medical Sp
4407 Willard Avenue, Chevy Chase

Want your business to be the top-listed health & beauty business in Potomac?